Skip to main content
Top
Published in: Cancer Causes & Control 4/2010

01-04-2010 | Original paper

Genes involved with folate uptake and distribution and their association with colorectal cancer risk

Authors: Jane C. Figueiredo, A. Joan Levine, Won H. Lee, David V. Conti, Jenny N. Poynter, Peter T. Campbell, David Duggan, Juan Pablo Lewinger, Maria Elena Martinez, Cornelia M. Ulrich, Polly Newcomb, John Potter, Paul J. Limburg, John Hopper, Mark A. Jenkins, Loic Le Marchand, John A. Baron, Robert W. Haile

Published in: Cancer Causes & Control | Issue 4/2010

Login to get access

Abstract

Folate status is an important predictor of colorectal cancer risk. Common genetic variants in genes involved in regulating cellular folate levels might also predict risk, but there are limited data on this issue. We conducted a family-based case–control association study of variants in four genes involved in folate uptake and distribution: FOLR1, FPGS, GGH and SLC19A1, using 1,750 population-based and 245 clinic-based cases of pathologically confirmed colorectal cancer and their unaffected relatives participating in the Colon Cancer Family Registries. Standardized questionnaires, administered to all participants, collected information on risk factors and diet. Standard molecular techniques were used to determine microsatellite instability (MSI) status on cases. tagSNPs (n = 29) were selected based on coverage as assessed by pairwise r 2. We found no evidence that tagSNPs in these genes were associated with risk of colorectal cancer. For the SLC19A1-rs1051266 (G80A, Arg27His) missense polymorphism, the A/A genotype was not associated with risk of colorectal cancer using population-based (OR = 1.00; 95% CI = 0.81–1.23) or clinic-based (OR = 0.75; 95% CI = 0.44–1.29) families compared to the G/A and G/G genotypes. We found no evidence that the association between any tagSNP and CRC risk was modified by multivitamin use, folic acid use and dietary folate intake and total folate intake. The odds ratios were similar, irrespective of MSI status, tumor subsite and family history of colorectal cancer. In conclusion, we found no significant evidence that genetic variants in FOLR1, GGH, FPGS and SLC19A1 are associated with the risk of colorectal cancer.
Literature
1.
go back to reference Kim YI (2003) Role of folate in colon cancer development and progression. J Nutr 133:3731S–3739SPubMed Kim YI (2003) Role of folate in colon cancer development and progression. J Nutr 133:3731S–3739SPubMed
2.
go back to reference Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413S–2418SPubMed Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413S–2418SPubMed
3.
go back to reference Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132:2350S–2355SPubMed Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132:2350S–2355SPubMed
4.
go back to reference Kim YI (2004) Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80:1123–1128PubMed Kim YI (2004) Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80:1123–1128PubMed
5.
go back to reference Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Jama 297:2351–2359CrossRefPubMed Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Jama 297:2351–2359CrossRefPubMed
6.
go back to reference Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH (2007) A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomark Prev 16:1325–1329CrossRef Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH (2007) A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomark Prev 16:1325–1329CrossRef
7.
go back to reference Ulrich CM, Potter JD (2006) Folate supplementation: too much of a good thing? Cancer Epidemiol Biomark Prev 15:189–193CrossRef Ulrich CM, Potter JD (2006) Folate supplementation: too much of a good thing? Cancer Epidemiol Biomark Prev 15:189–193CrossRef
8.
9.
go back to reference Ulrich CM (2007) Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 86:271–273PubMed Ulrich CM (2007) Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 86:271–273PubMed
10.
go back to reference Kim YI (2006) Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55:1387–1389CrossRefPubMed Kim YI (2006) Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55:1387–1389CrossRefPubMed
11.
go back to reference Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA (2008) Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomark Prev 17:2625–2631CrossRef Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA (2008) Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomark Prev 17:2625–2631CrossRef
12.
go back to reference Reed MC, Nijhout HF, Neuhouser ML, Gregory JF III, Shane B, James SJ, Boynton A, Ulrich CM (2006) A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 136:2653–2661PubMed Reed MC, Nijhout HF, Neuhouser ML, Gregory JF III, Shane B, James SJ, Boynton A, Ulrich CM (2006) A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 136:2653–2661PubMed
13.
go back to reference Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D (2000) Glutamyl hydrolase, pharmacological role and enzymatic characterization. Pharmacol Ther 85:207–215CrossRefPubMed Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D (2000) Glutamyl hydrolase, pharmacological role and enzymatic characterization. Pharmacol Ther 85:207–215CrossRefPubMed
14.
go back to reference Sierra EE, Goldman ID (1999) Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin Oncol 26:11–23PubMed Sierra EE, Goldman ID (1999) Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin Oncol 26:11–23PubMed
15.
go back to reference Spiegelstein O, Eudy JD, Finnell RH (2000) Identification of two putative novel folate receptor genes in humans and mouse. Gene 258:117–125CrossRefPubMed Spiegelstein O, Eudy JD, Finnell RH (2000) Identification of two putative novel folate receptor genes in humans and mouse. Gene 258:117–125CrossRefPubMed
16.
go back to reference Matherly LH (2001) Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol 67:131–162CrossRefPubMed Matherly LH (2001) Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol 67:131–162CrossRefPubMed
17.
go back to reference Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M (1992) Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 44:1898–1901CrossRefPubMed Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M (1992) Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 44:1898–1901CrossRefPubMed
18.
go back to reference Lowe KE, Osborne CB, Lin BF, Kim JS, Hsu JC, Shane B (1993) Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-gamma-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-gamma-glutamate specificity of metabolic cycles of one-carbon metabolism. J Biol Chem 268:21665–21673PubMed Lowe KE, Osborne CB, Lin BF, Kim JS, Hsu JC, Shane B (1993) Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-gamma-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-gamma-glutamate specificity of metabolic cycles of one-carbon metabolism. J Biol Chem 268:21665–21673PubMed
19.
go back to reference Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D (2007) Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomark Prev 16:2331–2343CrossRef Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D (2007) Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomark Prev 16:2331–2343CrossRef
20.
go back to reference Witte JS, Gauderman WJ, Thomas DC (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149:693–705PubMed Witte JS, Gauderman WJ, Thomas DC (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149:693–705PubMed
21.
go back to reference Stram DO, Hankin JH, Wilkens LR, Pike MC, Monroe KR, Park S, Henderson BE, Nomura AM, Earle ME, Nagamine FS, Kolonel LN (2000) Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 151:358–370PubMed Stram DO, Hankin JH, Wilkens LR, Pike MC, Monroe KR, Park S, Henderson BE, Nomura AM, Earle ME, Nagamine FS, Kolonel LN (2000) Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 151:358–370PubMed
22.
go back to reference Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Jama 293:1979–1985CrossRefPubMed Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Jama 293:1979–1985CrossRefPubMed
23.
go back to reference World Health Organization (2000) International classification of diseases for oncology. WHO, Geneva World Health Organization (2000) International classification of diseases for oncology. WHO, Geneva
24.
go back to reference Edlund CK, Lee WH, Li D, Van Den Berg DJ, Conti DV (2008) Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics 9:174CrossRefPubMed Edlund CK, Lee WH, Li D, Van Den Berg DJ, Conti DV (2008) Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics 9:174CrossRefPubMed
25.
go back to reference Siegmund KD, Langholz B, Kraft P, Thomas DC (2000) Testing linkage disequilibrium in sibships. Am J Hum Genet 67:244–248CrossRefPubMed Siegmund KD, Langholz B, Kraft P, Thomas DC (2000) Testing linkage disequilibrium in sibships. Am J Hum Genet 67:244–248CrossRefPubMed
26.
go back to reference Chatzikyriakidou A, Vakalis KV, Kolaitis N, Kolios G, Naka KK, Michalis LK, Georgiou I (2008) Distinct association of SLC19A1 polymorphism -43T > C with red cell folate levels and of MTHFR polymorphism 677C > T with plasma folate levels. Clin Biochem 41:174–176CrossRefPubMed Chatzikyriakidou A, Vakalis KV, Kolaitis N, Kolios G, Naka KK, Michalis LK, Georgiou I (2008) Distinct association of SLC19A1 polymorphism -43T > C with red cell folate levels and of MTHFR polymorphism 677C > T with plasma folate levels. Clin Biochem 41:174–176CrossRefPubMed
27.
go back to reference Conneely KN, Boehnke M (2007) So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81(6):1158–1168CrossRef Conneely KN, Boehnke M (2007) So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81(6):1158–1168CrossRef
28.
go back to reference Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C (2008) Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17:2834–2848CrossRefPubMed Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C (2008) Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17:2834–2848CrossRefPubMed
29.
go back to reference Odin E, Wettergren Y, Nilsson S, Willen R, Carlsson G, Spears CP, Larsson L, Gustavsson B (2003) Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res 9:6012–6019PubMed Odin E, Wettergren Y, Nilsson S, Willen R, Carlsson G, Spears CP, Larsson L, Gustavsson B (2003) Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res 9:6012–6019PubMed
30.
go back to reference Moscow JA (1998) Methotrexate transport and resistance. Leuk Lymphoma 30:215–224PubMed Moscow JA (1998) Methotrexate transport and resistance. Leuk Lymphoma 30:215–224PubMed
31.
go back to reference Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP (2000) A polymorphism (80G- > A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:310–315CrossRefPubMed Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP (2000) A polymorphism (80G- > A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:310–315CrossRefPubMed
32.
go back to reference Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH (2006) Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr 83:708–713PubMed Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH (2006) Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr 83:708–713PubMed
33.
go back to reference Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M (2003) Effects of the glutamate carboxypeptidase II (GCP2 1561C > T) and reduced folate carrier (RFC1 80G > A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63:2280–2285CrossRefPubMed Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M (2003) Effects of the glutamate carboxypeptidase II (GCP2 1561C > T) and reduced folate carrier (RFC1 80G > A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63:2280–2285CrossRefPubMed
34.
go back to reference Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J (2007) Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 28:856–865CrossRefPubMed Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J (2007) Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 28:856–865CrossRefPubMed
35.
go back to reference Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, Sherman M, Garcia-Closas M (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 120:2696–2703CrossRefPubMed Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, Sherman M, Garcia-Closas M (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 120:2696–2703CrossRefPubMed
36.
go back to reference Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML (2005) Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomark Prev 14:2509–2516CrossRef Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML (2005) Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomark Prev 14:2509–2516CrossRef
37.
go back to reference Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452–2458CrossRefPubMed Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452–2458CrossRefPubMed
38.
go back to reference Wang L, Chen W, Wang J, Tan Y, Zhou Y, Ding W, Hua Z, Shen J, Xu Y, Shen H (2006) Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population. Eur J Cancer 42:3206–3211CrossRefPubMed Wang L, Chen W, Wang J, Tan Y, Zhou Y, Ding W, Hua Z, Shen J, Xu Y, Shen H (2006) Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population. Eur J Cancer 42:3206–3211CrossRefPubMed
39.
go back to reference Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28(8):1672–1679CrossRefPubMed Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28(8):1672–1679CrossRefPubMed
40.
go back to reference Iwakiri S, Sonobe M, Nagai S, Hirata T, Wada H, Miyahara R (2008) Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol 15:889–899CrossRefPubMed Iwakiri S, Sonobe M, Nagai S, Hirata T, Wada H, Miyahara R (2008) Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol 15:889–899CrossRefPubMed
41.
go back to reference Allard JE, Risinger JI, Morrison C, Young G, Rose GS, Fowler J, Berchuck A, Maxwell GL (2007) Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. Gynecol Oncol 107:52–57CrossRefPubMed Allard JE, Risinger JI, Morrison C, Young G, Rose GS, Fowler J, Berchuck A, Maxwell GL (2007) Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. Gynecol Oncol 107:52–57CrossRefPubMed
42.
go back to reference Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, Salbaum JM, Kappen C, Weeks BR, James J, Bozinov D, Lupton JR, Chapkin RS (2005) Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65:887–897PubMed Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, Salbaum JM, Kappen C, Weeks BR, James J, Bozinov D, Lupton JR, Chapkin RS (2005) Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65:887–897PubMed
43.
go back to reference Kelemen LE (2006) The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 119:243–250CrossRefPubMed Kelemen LE (2006) The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 119:243–250CrossRefPubMed
44.
go back to reference Borjel AK, Yngve A, Sjostrom M, Nilsson TK (2006) Novel mutations in the 5′-UTR of the FOLR1 gene. Clin Chem Lab Med 44:161–167CrossRefPubMed Borjel AK, Yngve A, Sjostrom M, Nilsson TK (2006) Novel mutations in the 5′-UTR of the FOLR1 gene. Clin Chem Lab Med 44:161–167CrossRefPubMed
45.
go back to reference Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602–13609PubMed Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602–13609PubMed
46.
go back to reference Chave KJ, Ryan TJ, Chmura SE, Galivan J (2003) Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms. Gene 319:167–175CrossRefPubMed Chave KJ, Ryan TJ, Chmura SE, Galivan J (2003) Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms. Gene 319:167–175CrossRefPubMed
47.
go back to reference DeVos L, Chanson A, Liu Z, Ciappio ED, Parnell LD, Mason JB, Tucker KL, Crott JW (2008) Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am J Clin Nutr 88:1149–1158PubMed DeVos L, Chanson A, Liu Z, Ciappio ED, Parnell LD, Mason JB, Tucker KL, Crott JW (2008) Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am J Clin Nutr 88:1149–1158PubMed
48.
go back to reference Leil TA, Endo C, Adjei AA, Dy GK, Salavaggione OE, Reid JR, Ames MM (2007) Identification and characterization of genetic variation in the folylpolyglutamate synthase gene. Cancer Res 67:8772–8782CrossRefPubMed Leil TA, Endo C, Adjei AA, Dy GK, Salavaggione OE, Reid JR, Ames MM (2007) Identification and characterization of genetic variation in the folylpolyglutamate synthase gene. Cancer Res 67:8772–8782CrossRefPubMed
49.
go back to reference Lee KM, Lan Q, Kricker A, Purdue MP, Grulich AE, Vajdic CM, Turner J, Whitby D, Kang D, Chanock S, Rothman N, Armstrong BK (2007) One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122:525–533CrossRefPubMed Lee KM, Lan Q, Kricker A, Purdue MP, Grulich AE, Vajdic CM, Turner J, Whitby D, Kang D, Chanock S, Rothman N, Armstrong BK (2007) One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122:525–533CrossRefPubMed
50.
go back to reference Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 109:3050–3059PubMed Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 109:3050–3059PubMed
51.
go back to reference Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed
52.
go back to reference Liu K (1988) Measurement error and its impact on partial correlation and multiple linear regression analyses. Am J Epidemiol 127:864–874PubMed Liu K (1988) Measurement error and its impact on partial correlation and multiple linear regression analyses. Am J Epidemiol 127:864–874PubMed
Metadata
Title
Genes involved with folate uptake and distribution and their association with colorectal cancer risk
Authors
Jane C. Figueiredo
A. Joan Levine
Won H. Lee
David V. Conti
Jenny N. Poynter
Peter T. Campbell
David Duggan
Juan Pablo Lewinger
Maria Elena Martinez
Cornelia M. Ulrich
Polly Newcomb
John Potter
Paul J. Limburg
John Hopper
Mark A. Jenkins
Loic Le Marchand
John A. Baron
Robert W. Haile
Publication date
01-04-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 4/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9489-6

Other articles of this Issue 4/2010

Cancer Causes & Control 4/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine